Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Opinion & Analysis Amgen Inc AMGN

Healthcare Biotechnology
Amgen Inc. is a biotechnology company. The Company discovers, develops, manufactures and delivers various human therapeutics. It focuses on areas of high unmet medical need and leverages its expertise to strive for solutions that improve health outcomes and improve people's lives. It operates in human therapeutics segment. The Company’s marketed products portfolio includes Aranesp, ENBREL... see more

Opinion & Analysis (NDAQ:AMGN)

Morning Market Outlook for May 6, 2024

TheUpTrend 7 hours ago

Use stock volatility to invest in innovative oncology companies: JMP Security's Michael King Jr.

Gail Dutton October 15, 2015

Biotech Bears Spark Good Vibes For These ETFs

Benzinga.com  October 6, 2015

BTIG's Hartaj Singh's advice for biotech investors: 'hold your powder' 'til winter

Gail Dutton October 1, 2015

The Other Bearish Biotech ETF Is Looking Groovy, Too

Benzinga.com  August 21, 2015

Even With Recent Declines, Investors Still Love Biotech ETFs

Benzinga.com  July 30, 2015

A Big Day For Biotech And It's Not Going So Well

Benzinga.com  July 27, 2015

Play the gap to profit from Australia's undervalued biotech gems: John Hester of Bell Potter Securities

George S. Mack July 22, 2015

Zacks' Jason Napodano is not focused on a biotech bubble

George S. Mack July 9, 2015

ProShares Releases 2 New Leveraged Biotech ETFs

Benzinga.com  June 23, 2015

Biotech ETFs Hit New 2015 Highs

Benzinga.com  June 18, 2015

Capitalize on comeback stories in micro-cap biotech: Joe Pantginis of ROTH Capital Partners

George S. Mack June 17, 2015

The Best And Worst ETFs Of The Week Amid Biotech Rebound

Benzinga.com  May 9, 2015

3 Biotech ETFs Rally On Merger News

Benzinga.com  December 8, 2014

A Look At 3 Overbought ETFs

Benzinga.com  December 2, 2014

Buy These Top Ranked ETFs on Solid Biotech Stock Earnings - ETF News And Commentary

Benzinga.com  October 30, 2014

Drug ETFs Attractive Buys On Pullback

Benzinga.com  October 22, 2014

Biotech ETFs Hitting New Highs On Takeover News (FBT, PBE, ITMN)

Benzinga.com  August 27, 2014

Healthcare ETFs Leading the Pack This Q2 Earnings - ETF News And Commentary

Benzinga.com  August 7, 2014

Biotech ETFs Come Back Down To Earth

Benzinga.com  March 27, 2014